Alan M Siegel
Examiner (ID: 12850)
Most Active Art Unit | 1206 |
Art Unit(s) | 1206, 3506, 1103, 1203, 1621, 1204 |
Total Applications | 1919 |
Issued Applications | 1371 |
Pending Applications | 37 |
Abandoned Applications | 511 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18953379
[patent_doc_number] => 20240041706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SKIN DOUGH COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/365607
[patent_app_country] => US
[patent_app_date] => 2023-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18365607
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/365607 | SKIN DOUGH COMPOSITION | Aug 3, 2023 | Pending |
Array
(
[id] => 18784739
[patent_doc_number] => 20230372358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/225849
[patent_app_country] => US
[patent_app_date] => 2023-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225849
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225849 | PHARMACEUTICAL COMPOSITIONS COMPRISING A RYANODINE RECEPTOR MODULATOR AND USES THEREOF | Jul 24, 2023 | Pending |
Array
(
[id] => 18752271
[patent_doc_number] => 20230355490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => NON-THERAPEUTIC USE OF A BIODEGRADABLE HYDROCARBON OIL
[patent_app_type] => utility
[patent_app_number] => 18/224958
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18224958
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/224958 | NON-THERAPEUTIC USE OF A BIODEGRADABLE HYDROCARBON OIL | Jul 20, 2023 | Pending |
Array
(
[id] => 18752277
[patent_doc_number] => 20230355496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/222431
[patent_app_country] => US
[patent_app_date] => 2023-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222431 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | Jul 14, 2023 | Pending |
Array
(
[id] => 18769348
[patent_doc_number] => 20230364107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/221784
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18221784
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/221784 | Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof | Jul 12, 2023 | Issued |
Array
(
[id] => 18724146
[patent_doc_number] => 20230338266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => AQUEOUS COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/345797
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345797 | AQUEOUS COSMETIC | Jun 29, 2023 | Pending |
Array
(
[id] => 18672902
[patent_doc_number] => 20230310349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => NEW PHARMACEUTICAL DEVICE FOR USE IN INTRANASAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/323115
[patent_app_country] => US
[patent_app_date] => 2023-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/323115 | NEW PHARMACEUTICAL DEVICE FOR USE IN INTRANASAL ADMINISTRATION | May 23, 2023 | Pending |
Array
(
[id] => 18752272
[patent_doc_number] => 20230355491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => 1,2-ALKANEDIOLS AND A PROCESS FOR THEIR PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/195712
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195712
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/195712 | 1,2-ALKANEDIOLS AND A PROCESS FOR THEIR PRODUCTION | May 9, 2023 | Pending |
Array
(
[id] => 18595968
[patent_doc_number] => 20230270758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES
[patent_app_type] => utility
[patent_app_number] => 18/136443
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18136443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/136443 | PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES | Apr 18, 2023 | Pending |
Array
(
[id] => 18550682
[patent_doc_number] => 20230248682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID
[patent_app_type] => utility
[patent_app_number] => 18/188537
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188537
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188537 | COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID | Mar 22, 2023 | Pending |
Array
(
[id] => 18509878
[patent_doc_number] => 20230225961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
[patent_app_type] => utility
[patent_app_number] => 18/174858
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174858 | Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose | Feb 26, 2023 | |
Array
(
[id] => 18620360
[patent_doc_number] => 11753388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Composition for inhibiting alpha-glucosidase and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/081979
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4492
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081979 | Composition for inhibiting alpha-glucosidase and application thereof | Dec 14, 2022 | Issued |
Array
(
[id] => 18244964
[patent_doc_number] => 20230077275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => FABRICATION OF NANOWIRES AND HIERARCHICALLY POROUS MATERIALS THROUGH SUPERCRITICAL CO2 ASSISTED NEBULIZATION
[patent_app_type] => utility
[patent_app_number] => 17/986552
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17986552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/986552 | FABRICATION OF NANOWIRES AND HIERARCHICALLY POROUS MATERIALS THROUGH SUPERCRITICAL CO2 ASSISTED NEBULIZATION | Nov 13, 2022 | Pending |
Array
(
[id] => 18345216
[patent_doc_number] => 20230133326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => STABLE PHARMACEUTICAL COMPOSITIONS OF METFORMIN WITH CONTROL ON NITROSO IMPURITIES
[patent_app_type] => utility
[patent_app_number] => 17/975595
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975595 | STABLE PHARMACEUTICAL COMPOSITIONS OF METFORMIN WITH CONTROL ON NITROSO IMPURITIES | Oct 26, 2022 | Pending |
Array
(
[id] => 18140621
[patent_doc_number] => 20230014460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => BRACELET OR STRAP
[patent_app_type] => utility
[patent_app_number] => 17/934000
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934000 | BRACELET OR STRAP | Sep 20, 2022 | Pending |
Array
(
[id] => 18483587
[patent_doc_number] => 20230210886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ORGANOID AND ANTI-INFLAMMATORY AGENT FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/013770
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013770 | Pharmaceutical composition comprising organoid and anti-inflammatory agent for preventing or treating inflammatory bowel disease | Sep 15, 2022 | Issued |
Array
(
[id] => 19353083
[patent_doc_number] => 12053508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Topical therapeutic formulations
[patent_app_type] => utility
[patent_app_number] => 17/891835
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15624
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891835 | Topical therapeutic formulations | Aug 18, 2022 | Issued |
Array
(
[id] => 18374281
[patent_doc_number] => 20230149359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => STABLE PHARMACEUTICAL COMPOSITIONS OF CLONIDINE
[patent_app_type] => utility
[patent_app_number] => 17/866115
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866115 | STABLE PHARMACEUTICAL COMPOSITIONS OF CLONIDINE | Jul 14, 2022 | Pending |
Array
(
[id] => 17981216
[patent_doc_number] => 20220347252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/812068
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812068 | Formulations for weight loss and methods of use | Jul 11, 2022 | Issued |
Array
(
[id] => 19225504
[patent_doc_number] => 12005134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth
[patent_app_type] => utility
[patent_app_number] => 17/855206
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7572
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855206 | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth | Jun 29, 2022 | Issued |